Cite
HARVARD Citation
Varghese, D. et al. (n.d.). P632 Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence. Journal of Crohn's and colitis. pp. S524-S525. [Online].